AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 14 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 5.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $17,305,000,000 | +4.9% | 22,000,000 | 0.0% | 0.62% | +64.6% |
| Q3 2018 | $16,497,000,000 | +7.1% | 22,000,000 | 0.0% | 0.38% | +22.7% |
| Q2 2018 | $15,406,000,000 | -11.6% | 22,000,000 | 0.0% | 0.31% | -8.0% |
| Q1 2018 | $17,427,000,000 | -15.8% | 22,000,000 | -15.4% | 0.34% | -8.4% |
| Q4 2017 | $20,695,000,000 | +0.1% | 26,000,000 | 0.0% | 0.37% | +22.3% |
| Q3 2017 | $20,669,000,000 | -0.6% | 26,000,000 | 0.0% | 0.30% | -11.8% |
| Q2 2017 | $20,800,000,000 | +0.6% | 26,000,000 | 0.0% | 0.34% | -2.6% |
| Q1 2017 | $20,670,000,000 | -4.2% | 26,000,000 | -14.8% | 0.35% | -16.3% |
| Q4 2016 | $21,579,000,000 | +7.7% | 30,500,000 | 0.0% | 0.42% | +39.9% |
| Q3 2016 | $20,035,000,000 | +33.1% | 30,500,000 | +17.3% | 0.30% | -8.3% |
| Q2 2016 | $15,049,000,000 | +8.2% | 26,000,000 | 0.0% | 0.32% | +27.5% |
| Q1 2016 | $13,910,000,000 | -19.7% | 26,000,000 | 0.0% | 0.26% | -12.4% |
| Q4 2015 | $17,312,000,000 | +49.8% | 26,000,000 | +73.3% | 0.29% | +23.8% |
| Q3 2015 | $11,556,000,000 | – | 15,000,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
| EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
| Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
| UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
| Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
| Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
| CSS LLC/IL | 653,000 | $517,000 | 0.02% |
| Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |